Literature DB >> 24054326

A bloody mess: dendritic cells use hemophagocytosis to regulate viral inflammation.

Elizabeth Miller1, Nina Bhardwaj.   

Abstract

Previous studies have highlighted the immune-dampening effects of apoptotic cell uptake by phagocytes. Ohyagi et al. (2013) expose a unique mechanism of immune regulation during viral infection, which is mediated through phagocytosis of apoptotic red cells by dendritic cells.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2013        PMID： 24054326      PMCID： PMC3882075          DOI： 10.1016/j.immuni.2013.08.024

Source DB:  PubMed          Journal:  Immunity        ISSN： 1074-7613            Impact factor:   31.745


  10 in total

1.  Loss of integrin alpha(v)beta8 on dendritic cells causes autoimmunity and colitis in mice.

Authors:  Mark A Travis; Boris Reizis; Andrew C Melton; Emma Masteller; Qizhi Tang; John M Proctor; Yanli Wang; Xin Bernstein; Xiaozhu Huang; Louis F Reichardt; Jeffrey A Bluestone; Dean Sheppard
Journal:  Nature       Date:  2007-08-12       Impact factor: 49.962

2.  Interleukin-10 determines viral clearance or persistence in vivo.

Authors:  David G Brooks; Matthew J Trifilo; Kurt H Edelmann; Luc Teyton; Dorian B McGavern; Michael B A Oldstone
Journal:  Nat Med       Date:  2006-10-15       Impact factor: 53.440

3.  HIV-1 infection-induced apoptotic microparticles inhibit human DCs via CD44.

Authors:  Davor Frleta; Carolyn E Ochoa; Holger B Kramer; Shaukat Ali Khan; Andrea R Stacey; Persephone Borrow; Benedikt M Kessler; Barton F Haynes; Nina Bhardwaj
Journal:  J Clin Invest       Date:  2012-11-19       Impact factor: 14.808

4.  Disruption of MyD88 signaling suppresses hemophagocytic lymphohistiocytosis in mice.

Authors:  Philippe Krebs; Karine Crozat; Daniel Popkin; Michael B Oldstone; Bruce Beutler
Journal:  Blood       Date:  2011-05-06       Impact factor: 22.113

5.  Restoring function in exhausted CD8 T cells during chronic viral infection.

Authors:  Daniel L Barber; E John Wherry; David Masopust; Baogong Zhu; James P Allison; Arlene H Sharpe; Gordon J Freeman; Rafi Ahmed
Journal:  Nature       Date:  2005-12-28       Impact factor: 49.962

6.  Persistent LCMV infection is controlled by blockade of type I interferon signaling.

Authors:  John R Teijaro; Cherie Ng; Andrew M Lee; Brian M Sullivan; Kathleen C F Sheehan; Megan Welch; Robert D Schreiber; Juan Carlos de la Torre; Michael B A Oldstone
Journal:  Science       Date:  2013-04-12       Impact factor: 47.728

7.  Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response.

Authors:  Béatrice Jacquelin; Véronique Mayau; Brice Targat; Anne-Sophie Liovat; Désirée Kunkel; Gaël Petitjean; Marie-Agnès Dillies; Pierre Roques; Cécile Butor; Guido Silvestri; Luis D Giavedoni; Pierre Lebon; Françoise Barré-Sinoussi; Arndt Benecke; Michaela C Müller-Trutwin
Journal:  J Clin Invest       Date:  2009-12       Impact factor: 14.808

8.  Interleukin-10 promoter polymorphisms influence HIV-1 susceptibility and primary HIV-1 pathogenesis.

Authors:  Dshanta D Naicker; Lise Werner; Emil Kormuth; Jo-Ann Passmore; Koleka Mlisana; Salim Abdool Karim; Thumbi Ndung'u
Journal:  J Infect Dis       Date:  2009-08-01       Impact factor: 5.226

9.  Monocyte-derived dendritic cells perform hemophagocytosis to fine-tune excessive immune responses.

Authors:  Hideaki Ohyagi; Nobuyuki Onai; Taku Sato; Satoshi Yotsumoto; Jiajia Liu; Hisaya Akiba; Hideo Yagita; Koji Atarashi; Kenya Honda; Axel Roers; Werner Müller; Kazutaka Kurabayashi; Mayuka Hosoi-Amaike; Naoto Takahashi; Makoto Hirokawa; Kouji Matsushima; Kenichi Sawada; Toshiaki Ohteki
Journal:  Immunity       Date:  2013-09-12       Impact factor: 31.745

10.  Enhancing SIV-specific immunity in vivo by PD-1 blockade.

Authors:  Vijayakumar Velu; Kehmia Titanji; Baogong Zhu; Sajid Husain; Annette Pladevega; Lilin Lai; Thomas H Vanderford; Lakshmi Chennareddi; Guido Silvestri; Gordon J Freeman; Rafi Ahmed; Rama Rao Amara
Journal:  Nature       Date:  2008-12-10       Impact factor: 49.962
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.